Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
In consultation
In consultation: Guidance and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Consultation end date
Consultation end date
From date
To date
Apply date filters
Type
Type
Guidance (12)
Guidance programme
Guidance programme
Diagnostics guidance (1)
Highly specialised technologies guidance (1)
Interventional procedures guidance (2)
Technology appraisal guidance (8)
Apply filters
Showing 1 to 10 of 12
Sort by
Date
Title
Apply sorting
Guidance and quality standards in consultation
Title
Consultation
Type
Consultation end date
Denecimig (Mim8) for preventing bleeding episodes in haemophilia A in people 1 year and over ID6400
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
Technology appraisal guidance
15 January 2026
Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver
Draft scope consultation
Interventional procedures guidance
19 December 2025
In-situ normothermic regional perfusion of the abdomen for donor livers following circulatory death
Draft scope consultation
Interventional procedures guidance
19 December 2025
Tarlatamab for treating small-cell lung cancer that has progressed after platinum-based chemotherapy ID6617
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
Technology appraisal guidance
17 December 2025
Mirvetuximab soravtansine for treating folate receptor alpha-positive platinum-resistant advanced epithelial ovarian, fallopian tube or primary peritoneal cancer [ID6442]
Draft guidance
Technology appraisal guidance
17 December 2025
Pharmalgen for the treatment of bee and wasp venom allergy
Review proposal consultation
Technology appraisal guidance
16 December 2025
Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphoma
Review proposal consultation
Technology appraisal guidance
16 December 2025
Guidance on the use of electroconvulsive therapy
Review proposal consultation
Technology appraisal guidance
16 December 2025
Pharmalgen for the treatment of bee and wasp venom allergy
Review proposal consultation
Technology appraisal guidance
16 December 2025
Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome (review of HST31) [ID6598]
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
Highly specialised technology
15 December 2025
Current page
1
2
Page
1
of
2
Next page
Results per page
10
25
50
All
Back to top